JL
Insider selling
Jennifer L Taubert sold $4M of JNJ stock
Jennifer L Taubert, EVP, WWC. Innovative Medicine of Johnson & Johnson (JNJ), sold 15,000 shares of JNJ stock worth $4M, per an SEC Form 4 filed Aug 18, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Aug 17, 2026, 1 day before it was made public.
JNJ has moved +4.1% since the trade date, from $262.37 to $273.20 (Oct 30, 2026 close).
- Traded
- Aug 17, 2026
- Disclosed
- Aug 18, 2026
- Filing delay
- 1 day
- Price since
- +4.1%
- Role
- EVP, WWC. Innovative Medicine
- Source
- SEC Form 4
More JNJ insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.